Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534544 · ClinicalTrials.gov registry record
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
A clinical trial of Diabetes Mellitus, Type 1, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- 362
- Enrollment target
- 2
- Study locations
NCT03534544: Completed study of Diabetes Mellitus, Type 1, sponsored by Joslin Diabetes Center.
NCT03534544 is a study of Diabetes Mellitus, Type 1 that has completed, run by Joslin Diabetes Center. The registered enrollment target is 362 participants, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534544, a study of Diabetes Mellitus, Type 1, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- 362 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surveys. The results of the study will be used to assist in the design of a new automated insulin delivery system.
Primary Outcome
Semi-structured interviews with young persons with type 1 diabetes and parents; interviews will be transcribed and analyzed to derive central themes; this is a qualitative outcome
Conditions Studied
Study Locations (2)
Connecticut
- Yale University School of Medicine - New Haven
Massachusetts
- Joslin Diabetes Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 362 participants |
| Start Date | 2018-08-23 |
| Est. Completion | 2019-12-17 |
What the finished NCT03534544 record still lists
NCT03534544 is an observational study that tracks outcomes without assigning an intervention. The registered 362 participants enrollment target is mid-sized for trials with a published cap, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 0 interventions.
NCT03534544 reports a single indexed study location in Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03534544 about?
NCT03534544 is a clinical study titled "Patient and Parent Preferences for an On-Body Automated Insulin Delivery System". The goal of this study is to learn more about patient and family preferences regarding use of advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of young persons with type 1 diabetes will complete one study visit involving a semi-structured interview and surve...
What is the current status of trial NCT03534544?
This trial is currently completed. The enrollment target is 362 participants. The study started on 2018-08-23. Estimated completion is 2019-12-17.
What conditions does trial NCT03534544 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
Who is sponsoring clinical trial NCT03534544?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03534544 being conducted?
This trial has 2 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03534544's enrollment target sits among peer trials
362 20th of 118 higher than 98 of 118 other Diabetes Mellitus, Type 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI